Samuel Rubinstein

Samuel Rubinstein (senior executive) discloses dealings in STRATA Skin Sciences, Inc. to SEC (Form 4). Over a trading history stretching from 22 November 2019 to 18 November 2025, the count stands at 12 filings.

Market trades split into 3 purchases (€7,108) and 4 sales (€16k). Taken together, the sales exceed the purchases by €9,375. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants. In 2025 alone, the filings show 2 purchases and 3 sales.

Half of the purchases are above €2,619 and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 18 November 2025 with an open-market purchase (€2,619) in STRATA Skin Sciences, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.